Asadi Farkhondeh, Rahimi Milad, Ramezanghorbani Nahid, Almasi Sohrab
Department of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Development & Coordination Scientific Information and Publications, Deputy of Research & Technology, Ministry of Health & Medical Education, Tehran, Iran.
Cancer Rep (Hoboken). 2025 Mar;8(3):e70138. doi: 10.1002/cnr2.70138.
This systematic review investigates the use of machine learning (ML) algorithms in predicting survival outcomes for ovarian cancer (OC) patients. Key prognostic endpoints, including overall survival (OS), recurrence-free survival (RFS), progression-free survival (PFS), and treatment response prediction (TRP), are examined to evaluate the effectiveness of these algorithms and identify significant features that influence predictive accuracy.
A thorough search of four major databases-PubMed, Scopus, Web of Science, and Cochrane-resulted in 2400 articles published within the last decade, with 32 studies meeting the inclusion criteria. Notably, most publications emerged after 2021. Commonly used algorithms for survival prediction included random forest, support vector machines, logistic regression, XGBoost, and various deep learning models. Evaluation metrics such as area under the curve (AUC) (18 studies), concordance index (C-index) (11 studies), and accuracy (11 studies) were frequently employed. Age at diagnosis, tumor stage, CA-125 levels, and treatment-related factors were consistently highlighted as significant predictors, emphasizing their relevance in OC prognosis.
ML models demonstrate considerable potential for predicting OC survival outcomes; however, challenges persist regarding model accuracy and interpretability. Incorporating diverse data types-such as clinical, imaging, and molecular datasets-holds promise for enhancing predictive capabilities. Future advancements will depend on integrating heterogeneous data sources with multimodal ML approaches, which are crucial for improving prognostic precision in OC.
本系统评价研究了机器学习(ML)算法在预测卵巢癌(OC)患者生存结局中的应用。对包括总生存期(OS)、无复发生存期(RFS)、无进展生存期(PFS)和治疗反应预测(TRP)在内的关键预后终点进行了研究,以评估这些算法的有效性,并确定影响预测准确性的显著特征。
对四个主要数据库——PubMed、Scopus、科学网和考科蓝图书馆进行全面检索,结果显示在过去十年内发表了2400篇文章,其中32项研究符合纳入标准。值得注意的是,大多数出版物出现在2021年之后。常用的生存预测算法包括随机森林、支持向量机、逻辑回归、XGBoost以及各种深度学习模型。经常使用的评估指标如曲线下面积(AUC)(18项研究)、一致性指数(C指数)(11项研究)和准确率(11项研究)。诊断时的年龄、肿瘤分期、CA-125水平和治疗相关因素一直被强调为显著的预测因素,凸显了它们在OC预后中的相关性。
ML模型在预测OC生存结局方面显示出相当大的潜力;然而,在模型准确性和可解释性方面仍然存在挑战。纳入多种数据类型——如临床、影像和分子数据集——有望提高预测能力。未来的进展将取决于将异构数据源与多模态ML方法相结合,这对于提高OC的预后精度至关重要。